Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 36 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjectsHanna, J.; Foster, D.; Salter, A.; Somogyi, A.; White, J.; Bochner, F.
2004Changes in methadone concentration, opiod effects, and opioid withdrawal during induction onto maintenance treatmentAthanasos, P.; Morrish, G.; Somogyi, A.; Bochner, F.; White, J.
1997Slow-release oral morphine and LAAM: pharmacokinetics and pharmacodynamicsWhite, J.; Bochner, F.; Newcombe, D.; Somogyi, A.
1996Effect of omeprazole and cimetidine on the urinary metabolic ratio of proguanil in volunteers.Somogyi, A.; Reinhard, H.; Bochner, F.
1999Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationshipsDyer, K.; Foster, D.; White, J.; Somogyi, A.; Menelaou, A.; Bochner, F.
1996The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.Capon, D.; Bochner, F.; Kerry, N.; Mikus, G.; Danz, C.; Somogyi, A.
1999Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4Coller, J.; Somogyi, A.; Bochner, F.
1997Association between CYP2C19 genotype and proguanil oxidative polymorphism.Coller, J.; Somogyi, A.; Bochner, F.
1996Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism.Somogyi, A.; Reinhard, H.; Bochner, F.
1995Evaluation of the intestinal absorption of erythromycin in man: Absolute bioavailability and comparison with enteric coated erythromycinSomogyi, A.; Bochner, F.; Hetzel, D.; Williams, D.